Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2146 (LINC02146) is a human long non-coding RNA (lncRNA), specifically classified as a long intergenic non-coding RNA (lincRNA)[1][3]. LINC02146 does not encode a protein but is transcribed as a non-coding RNA longer than 200 nucleotides. While the detailed biological functions and disease involvements of LINC02146 itself are currently unclear in the literature, lincRNAs typically participate in the regulation of gene expression, chromatin organization, and may have enhancer-like functions[3]. Most lincRNAs are not considered direct therapeutic targets such as receptors or enzymes, but they may be associated with disease processes or considered as potential biomarkers or research targets in genomics[3]. There is no evidence that LINC02146 is currently used as a therapeutic target or that there are drugs developed to interact with it[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2146 (LINC02146).